South American Real Estate News
/ Category / AstraZeneca

The argentine firm behind AstraZeneca COVID vaccine Latam production sees April/May launch

The Argentine biotech firm working on the production of 400 million doses of an AstraZeneca COVID-19 vaccine for Latin America said on Friday it could begin shipping the active substance of the product to Mexico for completion.  Esteban Corley, director of mAbxience, the biotech firm, said he foresaw the finished product could be distributed in Latin America between April and May.  “Sometime in late February these materials will be exported to Mexico and in Mexico they will be formulated, filled…
Visit us on LinkedInVisit us on FacebookVisit us on TwitterVisit us on Pinterest